Device based treatment of heart failure

Area of Science:

• Cardiology
• Medical Devices
• Heart Failure Management

Background:

• Increasing prevalence of congestive cardiac failure due to aging population and improved survival from ischemic heart disease.
• Current medical treatments (ACE inhibitors, beta blockers, aldosterone antagonists) improve outcomes but a subset of patients still experience significant morbidity and mortality.
• Need for advanced therapeutic options for symptomatic heart failure patients refractory to optimal medical therapy.

Purpose of the Study:

• To evaluate the role of device-based treatments, specifically implantable cardioverter defibrillators (ICD) and cardiac resynchronisation therapy (CRT), in managing symptomatic heart failure.
• To assess the benefits of ICD and CRT, both individually and in combination, in improving patient outcomes.
• To highlight the synergistic effects of combined ICD and CRT devices in selected heart failure patients.

Main Methods:

• Review of existing clinical data and studies on ICD and CRT devices in heart failure management.
• Analysis of patient outcomes including mortality, morbidity, functional class, quality of life, and hospitalisation rates.
• Evaluation of the efficacy of combination devices delivering both ICD and CRT functions.

Main Results:

• Implantable cardioverter defibrillators (ICDs) have demonstrated a reduction in mortality in patients with severe heart failure.
• Cardiac resynchronisation therapy (CRT) improves functional class, quality of life, and physiological measures (e.g., peak Vo2), while reducing hospitalisations.
• Combination ICD and CRT devices show synergistic benefits in specific patient populations with heart failure.

Conclusions:

• Device-based therapies, including ICD and CRT, represent crucial advancements in treating symptomatic heart failure patients who have not responded adequately to medical management.
• ICDs and CRT offer distinct yet complementary benefits, addressing both arrhythmic risk and haemodynamic dysfunction.
• Combined ICD-CRT devices provide enhanced, synergistic benefits, offering a more comprehensive therapeutic strategy for selected heart failure patients, thereby improving overall prognosis and quality of life.